Related Experiment Videos
Vasotocin improves intelligence and attention in mentally retarded children
R Goldstein1, O Joja, D M Psatta
1Institute of Endocrinology, Bucharest, Romania.
Insights
Synthetic arginine vasotocin (AVT) significantly improved intelligence quotient (IQ) and attention in children with mental retardation (MR). These cognitive enhancements may stem from AVT
Area of Science:
- Neuroscience
- Pediatrics
- Pharmacology
Background:
- Mental retardation (MR) in prepubertal children presents significant cognitive challenges.
- Attention deficits are a common comorbidity in children with MR.
- Limited therapeutic options exist to improve cognitive function in this population.
Purpose of the Study:
- To investigate the effects of synthetic arginine vasotocin (AVT) on cognitive functions in prepubertal children with MR.
- To explore the potential of AVT as a therapeutic agent for improving attention and intelligence in MR.
- To examine the relationship between baseline cognitive scores and AVT treatment response.
Main Methods:
- A randomized, placebo-controlled study involving prepubertal children with MR.
- Intranasal administration of synthetic AVT (10(-6) mg/day/0.1 ml) for six months.
- Cognitive assessments including intelligence quotient (IQ), attention parameters, and short-term memory tests were conducted pre- and post-treatment.
Main Results:
- Synthetic AVT significantly increased IQ scores and improved attention parameters compared to oxytocin or saline.
- No significant effects on short-term memory were observed.
- A significant inverse correlation was found between pretreatment IQ/attention scores and their improvement after AVT treatment.
Conclusions:
- Synthetic AVT demonstrates potential as a therapeutic agent for enhancing cognitive functions, particularly attention, in prepubertal children with MR.
- The efficacy of AVT appears more pronounced in individuals with more significant attention deficits.
- AVT's effects may be mediated by its sleep-enhancing properties, potentially improving brain plasticity and attention performance in MR subjects.
Abstract:
In mentally retarded (MR) prepubertal children, investigated both before and after six months of treatment, synthetic arginine vasotocin (AVT) (10(-6) mg/day/0.1 ml, intranasally), but not oxytocin or saline alone, significantly increased the intelligence quotient (IQ) and improved the attention parameters without affecting the short-term memory. Taking into account both the psychometric results and the clinical observations, the effects of AVT could be mainly explained by assuming the improvement of attention. Since there was a significant inverse correlation between the pretreatment levels of the IQ and attention scores and their increase after AVT, and since the AVT effects tend to be more intense in autistic children, we hypothesize that the more affected the attention mechanisms, the more they are sensitive to AVT. The present results are tentatively explained by the paradoxical sleep-enhancing properties of AVT, mechanisms by which AVT could improve the brain plasticity in MR subjects and by this, the attention performance.